Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies
Crossref DOI link: https://doi.org/10.1186/s12933-015-0226-z
Published Online: 2015-05-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hermans, Michel P.
Bouenizabila, Evariste
Amoussou-guenou, Daniel K.
Ahn, Sylvie A.
Rousseau, Michel F.
License valid from 2015-05-21